2022_Oct_PODD_Boston_ Skyscraper2

Intract Pharma

Intract Pharma’s portfolio of oral delivery systems includes controlled-release technologies targeting specific regions of the large and small intestine, and a technology for enabling oral delivery of biotherapeutics previously only suitable for injection. It has also developed proprietary GI models.


Headquarters
Intract Pharma Ltd
Brunswick Square
Bloomsbury
WC1N 1AX
London
United Kingdom

Phone / Contact

T: +44 20 7753 5908
Top